Maitreya Medicare logo

Maitreya Medicare MD, chairman, board of directors and AGM

NSE: MAITREYAHealthcare Services

Last close ₹144.55up ₹7.55 (5.51%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹137.00.

52-week range of traded prices to 23 Oct 2026
₹103.10Low, 21 Sep 2026₹292.95High, 13 Nov 2025
Market cap
₹98 Cr
P/E
Lossover the last 12 months
P/B
3.5
Dividend yield
Nonein the last 12 months
ROE
−11.3%
Debt to equity
0.83
Volume, NSE
19,60067.4% delivered

Maitreya Medicare board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.

    An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

    Statutory auditor

    Named in the results for the quarter to Sep 2026.

    • Saherwala & Co.Peer-review certificate valid to Dec 2026

    A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

    Maitreya Medicare AGM and shareholder votes

    Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Maitreya Medicare share news and announcements

    Annual general meeting, 21 Sep 2026

    1,048 shareholders on the register on 14 Sep 2026; present: 2 promoters and 24 others; votes counted by JAISAL MOHATTA / JDM and Associates LLP.The company's voting result (opens in a new tab)

    1. 1 - To receive, consider and adopt the Audited Financial Statement of the Company for the financial year ended March 31, 2026 together with the reports of the Board of Directors and Auditors thereonand in this regard, pass the following resolutions as Ordinary ResolutionMoreLess
      Ordinary
      100.00% for0.00% against

      Against: promoters 0.00% · institutions 0.00% · other public 0.00%

      Turnout: all 58.05% · promoters 78.57% · institutions 0.00% · other public 2.24%

    2. 2 - Re-appointment of Mr. Vimalkumar Natverlal Patel (DIN: 08458999) as a Whole time Director who retires by rotation and being eligible offers himself for re-appointment.
      OrdinaryPromoters have an interest in it
      100.00% for0.00% against

      Against: promoters 0.00% · institutions 0.00% · other public 0.00%

      Turnout: all 58.05% · promoters 78.57% · institutions 0.00% · other public 2.24%

    For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

    Postal ballot, 17 Apr 2026, 1 resolution

    961 shareholders on the register on 13 Mar 2026; votes counted by JAISAL MOHATTA / JDM AND ASSOCIATES LLP.The company's voting result (opens in a new tab)

    1. To consider and approve ‘Maitreya Medicare Limited – Employee Stock Option Scheme 2026’
      Special
      100.00% for0.00% against

      Against: promoters 0.00% · institutions 0.00% · other public 0.00%

      Turnout: all 26.10% · promoters 35.69% · institutions 0.00% · other public 0.00%

    For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

    Investor complaints and compliance

    Quarter by quarter.

    Investor complaints received and resolved, the company's own count

    • Received
    • Resolved

    Open at the quarter's end

    None open at any quarter's end.
    The filing has a part on fines and penalties
    No
    The filing has a part on tax disputes
    No

    The company's own answers in its filing.

    How money raised was used

    Reported for the quarter to Sep 2026. A statement's amounts are left out where the raise it states and its own uses differ by fifty times or more, a figure typed at the wrong scale.

    RaisedAmount raisedForSet asideSpentSpent elsewhereReason and comments
    Public IssuesNov 2023–Making Investment through Equity in the subsidiary named ‘Maitreya Hospital Private Limited’ for setting up Hospital at Valsad, Gujarat––NoAudit committee: The Committee has noted that there is no deviation/ variation
    Public IssuesNov 2023–Redemption of part of issued Non-Convertible Redeemable––NoAudit committee: The Committee has noted that there is no deviation/ variation
    Public IssuesNov 2023–Funding the working capital requirements of the company––NoAudit committee: The Committee has noted that there is no deviation/ variation
    Public IssuesNov 2023–General Corporate Expenses––NoAudit committee: The Committee has noted that there is no deviation/ variation
    ₹ crore. Checked by is the agency appointed to monitor how the money is used. The reason and the comments are the company's, its audit committee's and its auditors' own words.